PharmaCielo Ltd (PCLOF)
0.1408
-0.03
(-16.43%)
USD |
OTCM |
May 31, 16:00
PharmaCielo Enterprise Value: 35.50M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 35.50M |
| May 30, 2024 | 40.07M |
| May 29, 2024 | 41.96M |
| May 28, 2024 | 40.07M |
| May 24, 2024 | 30.70M |
| May 23, 2024 | 30.70M |
| May 22, 2024 | 30.70M |
| May 21, 2024 | 40.07M |
| May 20, 2024 | 35.47M |
| May 17, 2024 | 30.69M |
| May 16, 2024 | 34.04M |
| May 15, 2024 | 33.88M |
| May 14, 2024 | 33.88M |
| May 13, 2024 | 36.25M |
| May 10, 2024 | 33.47M |
| May 09, 2024 | 35.59M |
| May 08, 2024 | 37.04M |
| May 07, 2024 | 31.62M |
| May 06, 2024 | 32.72M |
| May 03, 2024 | 32.51M |
| May 02, 2024 | 33.58M |
| May 01, 2024 | 33.43M |
| April 30, 2024 | 34.09M |
| April 29, 2024 | 32.39M |
| April 26, 2024 | 31.29M |
| Date | Value |
|---|---|
| April 25, 2024 | 31.05M |
| April 24, 2024 | 30.63M |
| April 23, 2024 | 31.76M |
| April 22, 2024 | 32.70M |
| April 19, 2024 | 33.38M |
| April 18, 2024 | 33.38M |
| April 17, 2024 | 35.24M |
| April 16, 2024 | 35.24M |
| April 15, 2024 | 34.53M |
| April 12, 2024 | 38.49M |
| April 11, 2024 | 41.63M |
| April 10, 2024 | 41.49M |
| April 09, 2024 | 44.29M |
| April 08, 2024 | 42.62M |
| April 05, 2024 | 44.02M |
| April 04, 2024 | 46.17M |
| April 03, 2024 | 40.49M |
| April 02, 2024 | 39.96M |
| April 01, 2024 | 36.75M |
| March 28, 2024 | 40.39M |
| March 27, 2024 | 37.75M |
| March 26, 2024 | 37.50M |
| March 25, 2024 | 33.27M |
| March 22, 2024 | 33.11M |
| March 21, 2024 | 30.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
24.40M
Minimum
Aug 21 2023
553.60M
Maximum
Jun 05 2019
112.47M
Average
59.17M
Median
Jun 03 2020
Enterprise Value Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | -5.135M |
| Venus Concept Inc | 75.68M |
| Juva Life Inc | -- |
| Lucy Scientific Discovery Inc | 2.383M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.057M |
| Revenue (Quarterly) | 0.2621M |
| Total Expenses (Quarterly) | 1.999M |
| EPS Diluted (Quarterly) | -0.0149 |
| Gross Profit Margin (Quarterly) | -99.29% |
| Profit Margin (Quarterly) | -784.9% |
| Earnings Yield | -42.09% |
| Normalized Earnings Yield | -37.90 |